IFNG and colitis: The secreted PGE2/IDO inhibited Th1 differentiation, while promoting Tregs differentiation, showing positive clinical outcomes in the mouse model of colitis, clearly reflecting the therapeutic potential of using IL-1β/IFN-γ for priming MSCs.